Literature DB >> 6102671

Plasma 6-keto-PGF1 alpha levels after plasma exchange in thrombotic thrombocytopenic purpura.

S J Machin, G Defreyn, D A Chamone, J Vermylen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6102671     DOI： 10.1016/s0140-6736(80)91160-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Plasmapheresis: technique and complications.

Authors:  P M Reimann; P D Mason
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

2.  Plasmapheresis in the haemolytic-uraemic syndrome in children.

Authors:  T J Beattie; A V Murphy; M L Willoughby; S J Machin; G Defreyn
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-23

3.  Prostacyclin and thromboxane A2 in thrombotic thrombocytopenic purpura.

Authors:  S H Lee; J S Wainscoat; H Zeitlin; F G Bolton; H A Leaver; A Seawright; J M Preece
Journal:  Br Med J (Clin Res Ed)       Date:  1981-11-21

4.  Haemolytic uraemic syndrome: therapeutic effect of plasma infusion.

Authors:  R Misiani; A C Appiani; A Edefonti; E Gotti; A Bettinelli; M Giani; E Rossi; G Remuzzi; G Mecca
Journal:  Br Med J (Clin Res Ed)       Date:  1982-11-06

5.  Plasmapheresis as a therapeutic measure in hemolytic-uremic syndrome in children.

Authors:  A Gillor; M Bulla; B Roth; K Bussmann; K Schrör; A Tekook; E Gladtke
Journal:  Klin Wochenschr       Date:  1983-04-01

6.  Inhibitor of prostacyclin production in sporadic haemolytic uraemic syndrome.

Authors:  M Levin; K B Elkon; T J Nokes; A M Buckle; M J Dillon; R M Hardisty; T M Barratt
Journal:  Arch Dis Child       Date:  1983-09       Impact factor: 3.791
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.